Research

Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome February 27, 2021

https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.13180

Learn more
Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/28166327

Learn more
Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/28628235

Learn more
Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471489/

Learn more
Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis February 27, 2021

http://casereports.bmj.com/content/2017/bcr-2016-218893.full

Learn more
From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time February 27, 2021

https://www.sciencedirect.com/science/article/pii/S156899721630163X

Learn more
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy February 27, 2021

https://www.sciencedirect.com/science/article/pii/S002839081730196X?via%3Dihub

Learn more
Clinical characterization of autoimmune LGI1 antibody limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/26896820

Learn more
Clinical characterization of autoimmune encephalitis and psychosis February 27, 2021

https://www.sciencedirect.com/science/article/pii/S0010440X16304539?via%3Dihub

Learn more
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/27037228

Learn more